1996
DOI: 10.1148/radiology.201.3.8939203
|View full text |Cite
|
Sign up to set email alerts
|

MR imaging of the meninges. Part II. Neoplastic disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
21
1
1

Year Published

1999
1999
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 59 publications
(24 citation statements)
references
References 0 publications
1
21
1
1
Order By: Relevance
“…Intracranial lesions were classified as dural, leptomeningeal, enhancing and nonenhancing parenchymal lesions, and cranial nerve enhancement according to criteria described by Fukui et al 15 and…”
Section: Methodsmentioning
confidence: 99%
“…Intracranial lesions were classified as dural, leptomeningeal, enhancing and nonenhancing parenchymal lesions, and cranial nerve enhancement according to criteria described by Fukui et al 15 and…”
Section: Methodsmentioning
confidence: 99%
“…Prospective multicentric cohort studies are required to confirm these findings and identify prognostic factors. Neoplastic pachymeningitis can be suspected preoperatively by the use of current imaging modalities such as contrast-enhanced MRI [20] and by medical history of a slowly progressive neurological impairment in absence of vertebral collapse [23], but both the surgeon and the patient should be aware that the diagnosis is more often performed intraoperatively. Appropriate statements about the risk of neurologic worsening or absence of recovery could be added to the informed consent and improve patient awareness of complications related to palliative surgical decompression.…”
Section: Discussionmentioning
confidence: 99%
“…The pathogenic mechanism of extradural enhancement may be attributable to the vascular dilatation of dural arteries and medullary and cortical veins to compensate for reduced CSF volume and a greater volume of gadolinium remaining in the dilated extradural microvasculature and diffusing into the extradural interstitial fluid (7,20). Non-hypotensive pachymeningeal enhancement may result from various dural tissue responses to infection, immunological mechanisms, systemic or regional granulomatosis, cancer metastasis, various connective tissue diseases, or other unknown causes (3,12,14,17,32). That is why the biochemical and microbiological examinations of CSF and the histopathological evaluation of dura and arachnoid mater were needed to assure the diagnosis of ICH.…”
Section: Discussionmentioning
confidence: 99%